- Sentinel lymph node detection in endometrial cancer: does injection site make a difference?
-
Bogani G, Martinelli F, Ditto A, Signorelli M, Chiappa V, Recalcati , Lorusso D, Raspagliesi F
- KMID: 2360253
- J Gynecol Oncol.
- 2016 Mar;27(2):e23.
- doi: 10.3802/jgo.2016.27.e23
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Morcellation of apparent benign uterine myoma: assessing risk to benefit ratio
-
Bogani G, Chiappa V, Ditto A, Martinelli F, Signorelli M, Lorusso D, Raspagliesi F
- KMID: 2374239
- J Gynecol Oncol.
- 2016 Jul;27(4):e37.
- doi: 10.3802/jgo.2016.27.e37
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A critical assessment on the role of sentinel node mapping in endometrial cancer
-
Bogani G, Ditto A, Martinelli F, Signorelli M, Perotto S, Lorusso D, Raspagliesi F
- KMID: 2345914
- J Gynecol Oncol.
- 2015 Oct;26(4):252-254.
- doi: 10.3802/jgo.2015.26.4.252
Endometrial cancer is the most common gynecologic malignancy in the developed countries. Although the high incidence of this occurrence no consensus, about the role of retroperitoneal staging, still exists. Growing... -
- CITED
-
- Close
- SHARE
-
- Close
- Gynecologic oncology at the time of COVID-19 outbreak
-
Bogani G, Brusadelli C, Guerrisi R, Lopez S, Signorelli M, Ditto A, Raspagliesi F
- KMID: 2511971
- J Gynecol Oncol.
- 2020 Jul;31(4):e72.
- doi: 10.3802/jgo.2020.31.e72
The World Health Organization (WHO) classified the novel coronavirus (i.e., coronavirus disease 2019 [COVID-19]) as a global public health emergency. COVID-19 threatens to curtail patient access to evidence-based treatment. Medicine... -
- CITED
-
- Close
- SHARE
-
- Close
- A score system for complete cytoreduction in selected recurrent ovarian cancer patients undergoing secondary cytoreductive surgery: predictors- and nomogram-based analyses
-
Bogani G, Tagliabue , Signorelli M, Ditto A, Martinelli F, Chiappa V, Mosca L, Sabatucci , Leone Roberti Maggiore U, Lorusso D, Raspagliesi F
- KMID: 2409941
- J Gynecol Oncol.
- 2018 May;29(3):e40.
- doi: 10.3802/jgo.2018.29.e40
OBJECTIVE: To test the applicability of the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) and Memorial Sloan Kettering (MSK) criteria in predicting complete cytoreduction (CC) in patients undergoing secondary cytoreductive surgery (SCS) for... -
- CITED
-
- Close
- SHARE
-
- Close
- Adjuvant sequential chemo and radiotherapy improves the oncological outcome in high risk endometrial cancer
-
Signorelli M, Lissoni AA, De Ponti E, Grassi T, Ponti S, Fruscio R
- KMID: 2345919
- J Gynecol Oncol.
- 2015 Oct;26(4):284-292.
- doi: 10.3802/jgo.2015.26.4.284
OBJECTIVE: Evaluation of the impact of sequential chemoradiotherapy in high risk endometrial cancer (EC). METHODS: Two hundred fifty-four women with stage IB grade 3, II and III EC (2009 FIGO staging),... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups
-
Bogani G, Apolone G, Ditto A, Scambia G, Panici PB, Angioli R, Pignata S, Greggi S, Scollo P, Delia M, Franchi M, Martinelli F, Signorelli M, Lopez S, Donato VD, Valabrega G, Ferrandina G, Palaia I, Bergamini A, Bocciolone L, Savarese A, Ghezzi F, Casarin J, Pinelli C, Trojano V, Chiantera V, Giorda G, Sopracordevole F, Malzoni M, Salerno G, Sartori E, Testa A, Zannoni G, Zullo F, Vizza E, Trojano G, Chiantera A, Raspagliesi F
- KMID: 2512057
- J Gynecol Oncol.
- 2020 Nov;31(6):e92.
- doi: 10.3802/jgo.2020.31.e92
Objective: Coronavirus disease 2019 (COVID-19) has caused rapid and drastic changes in cancer management. The Italian Society of Gynecology and Obstetrics (SIGO), and the Multicenter Italian Trials in Ovarian cancer... -
- CITED
-
- Close
- SHARE
-
- Close
